Pfizer mulling offer for Actavis
Pfizer, a listed New York City-based pharmaceuticals company, was said to be thinking about making a takeover bid for listed Irish-American rival Actavis, The Daily Telegraph reported. The newspaper did not cite a source for the rumour.
The article noted that the FTSE-100 pharmaceuticals group AstraZeneca rebuffed bid approaches from Pfizer this year. It was said that Pfizer had turned its attentions to Actavis rather than making a fresh bid for AstraZeneca, according to the report.
Actavis’ share price closed USD 1.64 (EUR 1.28) up at USD 234.38 in New York on Friday, 12 September, valuing the company at USD 61.93bn.
Source Daily Telegraph